Cite
APA Citation
Früh, M., & Peters, S. (2019). eGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer. Annals of oncology, 30, 1190–1192. http://access.bl.uk/ark:/81055/vdc_100092360414.0x00002e
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Früh, M., & Peters, S. (2019). eGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer. Annals of oncology, 30, 1190–1192. http://access.bl.uk/ark:/81055/vdc_100092360414.0x00002e